Piper-Vallillo, Andrew
first name: Andrew
last name: Piper-Vallillo
coauthor of: Hesketh, Paul
coauthor of: Bindal, Poorva
full name: Andrew J Piper-Vallillo MD
has faculty rank: Assistant Professor
has network: research areas
has network: coauthor of
has network: similar to
has network: selected publications
Person ID: 10248351
person in primary position: Assistant Professor
similar to: Weiss, Glen
similar to: Shin, Dong-Soo
similar to: Hesketh, Paul
similar to: Mazor, Kathleen
similar to: Servais, Elliot
type: Agent
type: Person
selected publications: Authorship 139406
selected publications: Authorship 131594
selected publications: Authorship 131787
selected publications: Authorship 131646
selected publications: Authorship 131769
selected publications: Authorship 131630
selected publications: Authorship 131892
selected publications: Authorship 131755
selected publications: Authorship 132028
selected publications: Authorship 131739
selected publications: Authorship 131886
selected publications: Authorship 131714
selected publications: Authorship 131736
selected publications: Authorship 131690
selected publications: Authorship 131716
selected publications: Authorship 131730
selected publications: Authorship 131688
selected publications: Authorship 131717
selected publications: Authorship 131746
selected publications: Authorship 131745
education and training: Fairfield University, Chemistry
education and training: University of Massachusetts Medical School,
research areas: Carcinoma, Non-Small-Cell Lung
research areas: Lung Neoplasms
research areas: Neoplasms
research areas: ErbB Receptors
research areas: Chemoradiotherapy
mailing address: Burlington MA 01805
middle name or initial: J
positions: Assistant Professor
positions: https://profiles.umassmed.edu/profile/69773143
phone: 781-744-8400
preferred title: Assistant Professor

coauthor of
tag name: prns:coAuthorOf
type: ObjectProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

author list
tag name: prns:hasAuthorList
type: DatatypeProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

has network
tag name: prns:hasNetwork
type: ObjectProperty

published in
tag name: prns:hasPublicationVenue
type: DatatypeProperty

information resource reference
tag name: prns:informationResourceReference
type: DatatypeProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

maximum weight
tag name: prns:maxWeight
type: DatatypeProperty

journal title abbreviation
tag name: prns:medlineTA
type: DatatypeProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

MeSH semantic group name
tag name: prns:meshSemanticGroupName
type: DatatypeProperty

minimum weight
tag name: prns:minWeight
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of connections
tag name: prns:numberOfConnections
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

publication date
tag name: prns:publicationDate
type: DatatypeProperty

similar to
tag name: prns:similarTo
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

educational organization
tag name: prns:trainingAtOrganization
type: DatatypeProperty

training location
tag name: prns:trainingLocation
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

year
tag name: prns:year
type: DatatypeProperty

Academic Article
type: Class

Article
type: Class

Document
type: Class

PubMed Identifier
tag name: bibo:pmid
type: DatatypeProperty

Address
type: Class

address line 1
tag name: vivo:address1
type: DatatypeProperty

address line 2
tag name: vivo:address2
type: DatatypeProperty

address line 3
tag name: vivo:address3
type: DatatypeProperty

selected publications
tag name: vivo:authorInAuthorship
type: ObjectProperty

author rank in publication
tag name: vivo:authorRank
type: DatatypeProperty
type: FunctionalProperty

Authorship
type: Class

degree earned
tag name: vivo:degreeEarned
type: ObjectProperty

Department
type: Class

Division
type: Class

education and training
tag name: vivo:educationalTraining
type: Class
type: ObjectProperty
label: Educational Training

research areas
tag name: vivo:hasResearchArea
type: ObjectProperty

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Information Resource
type: Class

linked author
tag name: vivo:linkedAuthor
type: ObjectProperty

linked information resource
tag name: vivo:linkedInformationResource
type: ObjectProperty

mailing address
tag name: vivo:mailingAddress
type: ObjectProperty

major field of degree
tag name: vivo:majorField
type: DatatypeProperty

middle name or initial
tag name: vivo:middleName
type: DatatypeProperty
type: FunctionalProperty

positions
tag name: vivo:personInPosition
type: ObjectProperty

phone
tag name: vivo:phoneNumber
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Lung Neoplasms
MeSH DescriptorUI: D008175
MeSH semantic group name: Disorders
number of authors: 237
number of publications: 676
uniqueness weight: 0.614721
type: Concept

Carcinoma, Non-Small-Cell Lung
MeSH DescriptorUI: D002289
MeSH semantic group name: Disorders
number of authors: 70
number of publications: 168
uniqueness weight: 0.856414
type: Concept

Neoplasms
MeSH DescriptorUI: D009369
MeSH semantic group name: Disorders
number of authors: 442
number of publications: 1364
uniqueness weight: 0.467931
type: Concept

Medicine
type: Department
type: Organization

Health Informatics And Implementation Science
type: Division
type: Organization

Hematology/Oncology
type: Division
type: Organization

T.H. Chan School of Medicine
type: Organization

UMass Chan Medical School
type: Organization

Mazor, Kathleen
first name: Kathleen
last name: Mazor
full name: Kathleen Mazor EdD
has faculty rank: Professor Emeritus
latitude: 42.29218100000000
longitude: -71.76031190000000
photo: https://profiles.umassmed.edu/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 217
person in primary position: Professor Emeritus
type: Agent
type: Person
preferred title: Professor Emeritus

Fairfield University, Chemistry
educational organization: Fairfield University
training location: Fairfield, CT, United States
type: EducationalTraining
degree earned: BS
major field of degree: Chemistry

University of Massachusetts Medical School,
educational organization: University of Massachusetts Medical School
training location: Worcester, MA, United States
type: EducationalTraining
degree earned: MD

ADJUNCT PROFESSOR
sort order: 46
type: Faculty Rank

Population and Quantitative Health Sciences
type: Department
type: Organization

Chemoradiotherapy
MeSH DescriptorUI: D059248
MeSH semantic group name: Procedures
number of authors: 29
number of publications: 67
uniqueness weight: 0.954131
type: Concept

ErbB Receptors
MeSH DescriptorUI: D066246
MeSH semantic group name: Chemicals & Drugs
number of authors: 72
number of publications: 114
uniqueness weight: 0.936587
type: Concept

Weiss, Glen
first name: Glen
last name: Weiss
full name: Glen Weiss MD, MBA
has faculty rank: Associate Professor
latitude: 42.27525000000000
longitude: -71.76233800000000
photo: https://profiles.umassmed.edu/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 10247163
person in primary position: Associate Professor
type: Agent
type: Person
preferred title: Associate Professor

Bindal, Poorva
first name: Poorva
last name: Bindal
full name: Poorva Bindal MD
has faculty rank: Assistant Professor
latitude: 42.27525000000000
longitude: -71.76233800000000
Person ID: 10247475
person in primary position: Assistant Professor
type: Agent
type: Person
preferred title: Assistant Professor

Time to SARS-CoV-2 clearance among patients with cancer and COVID-19.
PubMed Identifier: 33560590
author list: Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB
published in: Cancer medicine
information resource reference: Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB. Time to SARS-CoV-2 clearance among patients with cancer and COVID-19. Cancer Med. 2021 03; 10(5):1545-1549.
journal title abbreviation: Cancer Med
publication date: 2021-02-09T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19.
PubMed Identifier: 32743607
author list: Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB
published in: medRxiv : the preprint server for health sciences
information resource reference: Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB. Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. medRxiv. 2020 Jul 24.
journal title abbreviation: medRxiv
publication date: 2020-07-24T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Servais, Elliot
first name: Elliot
last name: Servais
full name: Elliot L Servais MD
has faculty rank: Chair And Associate Professor
latitude: 42.48526100000000
longitude: -71.20221980000000
Person ID: 10247632
person in primary position: Chair and Associate Professor
type: Agent
type: Person
preferred title: Chair and Associate Professor

Medicine at UMass Chan - Lahey
type: Department
type: Organization

Surgery at UMass Chan - Lahey
type: Department
type: Organization

Health System Science
type: Division
type: Organization

Assistant Professor
is primary position: true
position in department: Medicine
position in division: Hematology/Oncology
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

Hesketh, Paul
first name: Paul
last name: Hesketh
full name: Paul Joseph Hesketh MD
has faculty rank: Professor
latitude: 42.48462770000000
longitude: -71.20052790000000
Person ID: 10247887
person in primary position: Professor
type: Agent
type: Person
preferred title: Professor

Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School

Professor
sort order: 3
type: Faculty Rank

Professor Emeritus
sort order: 8
type: Faculty Rank

Assistant Professor
sort order: 13
type: Faculty Rank

Associate Professor
sort order: 10
type: Faculty Rank

Chair And Associate Professor
sort order: 38
type: Faculty Rank

Professor Emeritus
is primary position: true
position in department: Medicine
position in division: Health System Science
sort order: 1
type: Position
HR job title: Professor Emeritus
position in organization: UMass Chan Medical School

Associate Professor
is primary position: true
position in department: Medicine
position in division: Health System Science
sort order: 1
type: Position
HR job title: Associate Professor
position in organization: UMass Chan Medical School

Burlington MA 01805
type: Address
address line 1: Lahey Hospital and Medical Center
address line 2: 41 Mall Road
address line 3: Burlington MA 01805

https://profiles.umassmed.edu/profile/69773143
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 2
type: Position
position in organization: T.H. Chan School of Medicine

Assistant Professor
is primary position: true
position in department: Medicine at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Assistant Professor
position in organization: UMass Chan Medical School

research areas
maximum weight: 0.714612
minimum weight: 0.0217547
number of connections: 42
predicate node: https://profiles.umassmed.edu/profile/198
predicate: research areas
type: Network

coauthor of
maximum weight: 0.235047
minimum weight: 0.0865656
number of connections: 2
predicate node: https://profiles.umassmed.edu/profile/345
predicate: coauthor of
type: Network

similar to
maximum weight: 10.6484
minimum weight: 1.13201
number of connections: 60
predicate node: https://profiles.umassmed.edu/profile/476
predicate: similar to
type: Network

selected publications
maximum weight: 1
minimum weight: 1
number of connections: 20
predicate node: https://profiles.umassmed.edu/profile/94
predicate: selected publications
type: Network

Authorship 131594
type: Authorship
author rank in publication: 10
linked author: Piper-Vallillo, Andrew
linked information resource: Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.

Authorship 131630
type: Authorship
author rank in publication: 3
linked author: Piper-Vallillo, Andrew
linked information resource: Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer.

Authorship 131646
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice.

Authorship 131688
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A Review.

Authorship 131690
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations.

Authorship 131714
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Differential Pattern of Resistance and Sensitivity to Different Classes of MET Inhibitors for MET-Amplified Tumors With MET-D1228X or MET-Y1230X Mutations.

Authorship 131716
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19.

Authorship 131717
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?

Authorship 131730
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer.

Authorship 131736
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: Time to SARS-CoV-2 clearance among patients with cancer and COVID-19.

Authorship 131739
type: Authorship
author rank in publication: 6
linked author: Piper-Vallillo, Andrew
linked information resource: Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19.

Authorship 131745
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Cardiac Risk-Informed Treatment of?EGFR-Mutant Lung Cancer With?Osimertinib.

Authorship 131746
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: Heart?Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib.

Authorship 131755
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib.

Authorship 131769
type: Authorship
author rank in publication: 3
linked author: Piper-Vallillo, Andrew
linked information resource: Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.

Authorship 131787
type: Authorship
author rank in publication: 2
linked author: Piper-Vallillo, Andrew
linked information resource: The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice.
PubMed Identifier: 38539415
author list: Viray H, Piper-Vallillo AJ, Widick P, Academia E, Shea M, Rangachari D, VanderLaan PA, Kobayashi SS, Costa DB
published in: Cancers
information resource reference: Viray H, Piper-Vallillo AJ, Widick P, Academia E, Shea M, Rangachari D, VanderLaan PA, Kobayashi SS, Costa DB. A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice. Cancers (Basel). 2024 Mar 07; 16(6).
journal title abbreviation: Cancers (Basel)
publication date: 2024-03-07T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer.
PubMed Identifier: 33225315
author list: Piper-Vallillo AJ, Halbert BT, Rangachari D, Kobayashi SS, Costa DB
published in: JTO clinical and research reports
information resource reference: Piper-Vallillo AJ, Halbert BT, Rangachari D, Kobayashi SS, Costa DB. Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer. JTO Clin Res Rep. 2020 Nov 01; 1(4):100071.
journal title abbreviation: JTO Clin Res Rep
publication date: 2020-06-20T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
PubMed Identifier: 38761385
author list: Chang AEB, Piper-Vallillo AJ, Mak RH, Lanuti M, Muzikansky A, Rotow J, J?nne PA, Mino-Kenudson M, Swanson S, Wright CD, Kozono D, Marcoux P, Piotrowska Z, Sequist LV, Willers H
published in: The oncologist
information resource reference: Chang AEB, Piper-Vallillo AJ, Mak RH, Lanuti M, Muzikansky A, Rotow J, J?nne PA, Mino-Kenudson M, Swanson S, Wright CD, Kozono D, Marcoux P, Piotrowska Z, Sequist LV, Willers H. The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC. Oncologist. 2024 Jul 05; 29(7):609-618.
journal title abbreviation: Oncologist
publication date: 2024-07-05T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer.
PubMed Identifier: 36075183
author list: Sentana-Lledo D, Viray H, Piper-Vallillo AJ, Widick P, Rangachari D, Wilson JL, Gangadharan SP, Aronovitz JA, Berman SM, VanderLaan PA, Costa DB
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Sentana-Lledo D, Viray H, Piper-Vallillo AJ, Widick P, Rangachari D, Wilson JL, Gangadharan SP, Aronovitz JA, Berman SM, VanderLaan PA, Costa DB. Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer. Lung Cancer. 2022 10; 172:124-126.
journal title abbreviation: Lung Cancer
publication date: 2022-08-24T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Differential Pattern of Resistance and Sensitivity to Different Classes of MET Inhibitors for MET-Amplified Tumors With MET-D1228X or MET-Y1230X Mutations.
PubMed Identifier: 34589996
author list: Piper-Vallillo AJ, Kobayashi SS, Costa DB
published in: JTO clinical and research reports
information resource reference: Piper-Vallillo AJ, Kobayashi SS, Costa DB. Differential Pattern of Resistance and Sensitivity to Different Classes of MET Inhibitors for MET-Amplified Tumors With MET-D1228X or MET-Y1230X Mutations. JTO Clin Res Rep. 2021 Mar; 2(3):100133.
journal title abbreviation: JTO Clin Res Rep
publication date: 2021-03-16T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib.
PubMed Identifier: 34887193
author list: White MN, Piper-Vallillo AJ, Gardner RM, Cunanan K, Neal JW, Das M, Padda SK, Ramchandran K, Chen TT, Sequist LV, Piotrowska Z, Wakelee HA
published in: Clinical lung cancer
information resource reference: White MN, Piper-Vallillo AJ, Gardner RM, Cunanan K, Neal JW, Das M, Padda SK, Ramchandran K, Chen TT, Sequist LV, Piotrowska Z, Wakelee HA. Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib. Clin Lung Cancer. 2022 05; 23(3):e210-e221.
journal title abbreviation: Clin Lung Cancer
publication date: 2021-11-11T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations.
PubMed Identifier: 33205053
author list: Piper-Vallillo AJ, Mooradian MJ, Meador CB, Yeap BY, Peterson J, Sakhi M, Do A, Zubiri L, Stevens S, Vaughn J, Goodwin K, Gavralidis A, Willers H, Miller A, Farago A, Piotrowska Z, Lin JJ, Dagogo-Jack I, Lennes IT, Sequist LV, Temel JS, Heist RS, Digumarthy S, Reynolds KL, Gainor JF
published in: JTO clinical and research reports
information resource reference: Piper-Vallillo AJ, Mooradian MJ, Meador CB, Yeap BY, Peterson J, Sakhi M, Do A, Zubiri L, Stevens S, Vaughn J, Goodwin K, Gavralidis A, Willers H, Miller A, Farago A, Piotrowska Z, Lin JJ, Dagogo-Jack I, Lennes IT, Sequist LV, Temel JS, Heist RS, Digumarthy S, Reynolds KL, Gainor JF. Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations. JTO Clin Res Rep. 2021 Jan; 2(1):100124.
journal title abbreviation: JTO Clin Res Rep
publication date: 2020-11-12T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19.
PubMed Identifier: 33856099
author list: Klein IA, Rosenberg SM, Reynolds KL, Zubiri L, Rosovsky R, Piper-Vallillo AJ, Gao X, Boland G, Bardia A, Gaither R, Freeman H, Kirkner GJ, Rhee C, Klompas M, Baker MA, Wadleigh M, Winer EP, Kotton CN, Partridge AH
published in: The oncologist
information resource reference: Klein IA, Rosenberg SM, Reynolds KL, Zubiri L, Rosovsky R, Piper-Vallillo AJ, Gao X, Boland G, Bardia A, Gaither R, Freeman H, Kirkner GJ, Rhee C, Klompas M, Baker MA, Wadleigh M, Winer EP, Kotton CN, Partridge AH. Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. Oncologist. 2021 08; 26(8):685-693.
journal title abbreviation: Oncologist
publication date: 2021-05-12T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A Review.
PubMed Identifier: 32552277
author list: Piper-Vallillo AJ, Sequist LV, Piotrowska Z
published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
information resource reference: Piper-Vallillo AJ, Sequist LV, Piotrowska Z. Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A Review. J Clin Oncol. 2020 Jun 18; JCO1903123.
journal title abbreviation: J Clin Oncol
publication date: 2020-06-18T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
PubMed Identifier: 32776005
author list: Sehgal K, Piper-Vallillo AJ, Viray H, Khan AM, Rangachari D, Costa DB
published in: Precision cancer medicine
information resource reference: Sehgal K, Piper-Vallillo AJ, Viray H, Khan AM, Rangachari D, Costa DB. Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond? Precis Cancer Med. 2020 Jun; 3.
journal title abbreviation: Precis Cancer Med
publication date: 2020-06-15T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Cardiac Risk-Informed Treatment of?EGFR-Mutant Lung Cancer With?Osimertinib.
PubMed Identifier: 34396180
author list: Piper-Vallillo AJ, Sequist LV
published in: JACC. CardioOncology
information resource reference: Piper-Vallillo AJ, Sequist LV. Cardiac Risk-Informed Treatment of?EGFR-Mutant Lung Cancer With?Osimertinib. JACC CardioOncol. 2019 Dec; 1(2):179-181.
journal title abbreviation: JACC CardioOncol
publication date: 2019-12-17T00:00:00
year: 2019
type: Academic Article
type: Article
type: Document
type: Information Resource

Heart?Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib.
PubMed Identifier: 34396216
author list: Piper-Vallillo AJ, Costa DB, Sabe MA, Asnani A
published in: JACC. CardioOncology
information resource reference: Piper-Vallillo AJ, Costa DB, Sabe MA, Asnani A. Heart?Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib. JACC CardioOncol. 2020 Mar; 2(1):119-122.
journal title abbreviation: JACC CardioOncol
publication date: 2020-03-17T00:00:00
year: 2020
type: Academic Article
type: Article
type: Document
type: Information Resource

Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
PubMed Identifier: 39571252
author list: Osataphan S, Awidi M, Jan YJ, Gunturu K, Sundararaman S, Viray H, Frankenberger E, Mariano M, O'Loughlin L, Piper-Vallillo A, Stafford K, Kolnick A, Ghazalah H, Sehgal K, Patti ME, Costa D, Lam P, Rangachari D
published in: Lung cancer (Amsterdam, Netherlands)
information resource reference: Osataphan S, Awidi M, Jan YJ, Gunturu K, Sundararaman S, Viray H, Frankenberger E, Mariano M, O'Loughlin L, Piper-Vallillo A, Stafford K, Kolnick A, Ghazalah H, Sehgal K, Patti ME, Costa D, Lam P, Rangachari D. Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Lung Cancer. 2024 Dec; 198:108023.
journal title abbreviation: Lung Cancer
publication date: 2024-11-15T00:00:00
year: 2024
type: Academic Article
type: Article
type: Document
type: Information Resource

Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
PubMed Identifier: 36879929
author list: Ji J, Aredo JV, Piper-Vallillo A, Huppert L, Rotow JK, Husain H, Stewart S, Cobb R, Wakelee HA, Blakely CM, Wong ML, Gubens MA, Madani MH, Digumarthy SR, McCoach C, Piotrowska Z, Neal JW, Riess JW
published in: JTO clinical and research reports
information resource reference: Ji J, Aredo JV, Piper-Vallillo A, Huppert L, Rotow JK, Husain H, Stewart S, Cobb R, Wakelee HA, Blakely CM, Wong ML, Gubens MA, Madani MH, Digumarthy SR, McCoach C, Piotrowska Z, Neal JW, Riess JW. Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study. JTO Clin Res Rep. 2023 Mar; 4(3):100459.
journal title abbreviation: JTO Clin Res Rep
publication date: 2023-01-10T00:00:00
year: 2023
type: Academic Article
type: Article
type: Document
type: Information Resource

Authorship 131886
type: Authorship
author rank in publication: 90
linked author: Piper-Vallillo, Andrew
linked information resource: Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Authorship 131892
type: Authorship
author rank in publication: 1
linked author: Piper-Vallillo, Andrew
linked information resource: High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.

Authorship 132028
type: Authorship
author rank in publication: 4
linked author: Piper-Vallillo, Andrew
linked information resource: Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center.

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.
PubMed Identifier: 35637759
author list: Piper-Vallillo AJ, Rotow JK, Aredo JV, Shaverdashvili K, Luo J, Carlisle JW, Husain H, Muzikansky A, Heist RS, Rangachari D, Ramalingam SS, Wakelee HA, Yu HA, Sequist LV, Bauml JM, Neal JW, Piotrowska Z
published in: JTO clinical and research reports
information resource reference: Piper-Vallillo AJ, Rotow JK, Aredo JV, Shaverdashvili K, Luo J, Carlisle JW, Husain H, Muzikansky A, Heist RS, Rangachari D, Ramalingam SS, Wakelee HA, Yu HA, Sequist LV, Bauml JM, Neal JW, Piotrowska Z. High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience. JTO Clin Res Rep. 2022 Jun; 3(6):100328.
journal title abbreviation: JTO Clin Res Rep
publication date: 2022-04-21T00:00:00
year: 2022
type: Academic Article
type: Article
type: Document
type: Information Resource

Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer.
PubMed Identifier: 40256355
author list: Aglan M, Spyropoulous E, Oster J, Hesketh PJ, Piper-Vallillo AJ
published in: Respiratory medicine case reports
information resource reference: Aglan M, Spyropoulous E, Oster J, Hesketh PJ, Piper-Vallillo AJ. Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer. Respir Med Case Rep. 2025; 55:102200.
journal title abbreviation: Respir Med Case Rep
publication date: 2025-04-01T00:00:00
year: 2025
type: Academic Article
type: Article
type: Document
type: Information Resource

Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center.
PubMed Identifier: 33932247
author list: Zubiri L, Rosovsky RP, Mooradian MJ, Piper-Vallillo AJ, Gainor JF, Sullivan RJ, Marte D, Boland GM, Gao X, Hochberg EP, Ryan DP, McEwen C, Mai M, Sharova T, Soumerai TE, Bardia A, Reynolds KL
published in: The oncologist
information resource reference: Zubiri L, Rosovsky RP, Mooradian MJ, Piper-Vallillo AJ, Gainor JF, Sullivan RJ, Marte D, Boland GM, Gao X, Hochberg EP, Ryan DP, McEwen C, Mai M, Sharova T, Soumerai TE, Bardia A, Reynolds KL. Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center. Oncologist. 2021 08; 26(8):e1427-e1433.
journal title abbreviation: Oncologist
publication date: 2021-05-18T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
PubMed Identifier: 33746047
author list: Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G
published in: Annals of oncology : official journal of the European Society for Medical Oncology
information resource reference: Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 06; 32(6):787-800.
journal title abbreviation: Ann Oncol
publication date: 2021-03-19T00:00:00
year: 2021
type: Academic Article
type: Article
type: Document
type: Information Resource

Adjunct Professor
is primary position: true
position in department: Population and Quantitative Health Sciences
position in division: Health Informatics And Implementation Science
sort order: 1
type: Position
HR job title: Adjunct Professor
position in organization: UMass Chan Medical School

Shin, Dong-Soo
first name: Dong-Soo
last name: Shin
full name: Dong-Soo Shin PhD, RN
has faculty rank: ADJUNCT PROFESSOR
Person ID: 10248397
person in primary position: Adjunct Professor
type: Agent
type: Person
preferred title: Adjunct Professor

Authorship 139406
type: Authorship
author rank in publication: 5
linked author: Piper-Vallillo, Andrew
linked information resource: Safety and efficacy of osimertinib 160 mg daily given concurrently with a strong CYP3A4 inducer.

Chair and Associate Professor
is primary position: true
position in department: Surgery at UMass Chan - Lahey
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Chair and Associate Professor
position in organization: UMass Chan Medical School